Cite
High erythroferrone expression in CD71 + erythroid progenitors predicts superior survival in myelodysplastic syndromes.
MLA
Riabov, Vladimir, et al. “High Erythroferrone Expression in CD71 + Erythroid Progenitors Predicts Superior Survival in Myelodysplastic Syndromes.” British Journal of Haematology, vol. 192, no. 5, Mar. 2021, pp. 879–91. EBSCOhost, https://doi.org/10.1111/bjh.17314.
APA
Riabov, V., Mossner, M., Stöhr, A., Jann, J.-C., Streuer, A., Schmitt, N., Knaflic, A., Nowak, V., Weimer, N., Obländer, J., Palme, I., Schumann, C., Baldus, C. D., Schulze, T. J., Wuchter, P., Röhl, H., Jawhar, A., Weiss, C., Boch, T., … Nowak, D. (2021). High erythroferrone expression in CD71 + erythroid progenitors predicts superior survival in myelodysplastic syndromes. British Journal of Haematology, 192(5), 879–891. https://doi.org/10.1111/bjh.17314
Chicago
Riabov, Vladimir, Maximilian Mossner, Alexandra Stöhr, Johann-Christoph Jann, Alexander Streuer, Nanni Schmitt, Antje Knaflic, et al. 2021. “High Erythroferrone Expression in CD71 + Erythroid Progenitors Predicts Superior Survival in Myelodysplastic Syndromes.” British Journal of Haematology 192 (5): 879–91. doi:10.1111/bjh.17314.